Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Recommendation of “Moderate Buy” by Analysts
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-six ratings firms that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation, eighteen have given a buy recommendation and two have assigned a strong buy recommendation to […]
14 Jun 09:23 · The Markets Daily